CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2

Peiyi Xie1, Hui Wang2, Jiayu Fang3

  • 1Department of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang, China.

Endocrinology
|January 28, 2021
PubMed

Insights

COP9 signalosome subunit 5 (CSN5) promotes thyroid cancer growth and spread by stabilizing angiopoietin-like protein 2 (ANGPTL2). This discovery highlights CSN5 as a potential therapeutic target for thyroid carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • COP9 signalosome subunit 5 (CSN5) is implicated in various cancers.
  • CSN5 stabilizes proteins via deubiquitylation.
  • The role of CSN5 in thyroid carcinoma remains uncharacterized.

Purpose of the Study:

  • To investigate the role and mechanism of CSN5 in thyroid carcinoma.
  • To determine if CSN5 influences thyroid carcinoma cell proliferation and metastasis.
  • To explore the relationship between CSN5 and angiopoietin-like protein 2 (ANGPTL2) in thyroid cancer.

Main Methods:

  • Quantitative analysis of CSN5 expression in thyroid carcinoma tissues.
  • In vitro gain-and-loss functional assays to assess cell proliferation and metastasis.
  • Correlation analysis between CSN5 and ANGPTL2 protein levels.
  • Mechanism studies involving protein binding, ubiquitination, and degradation assays.

Main Results:

  • CSN5 is significantly overexpressed in thyroid carcinoma tissues.
  • CSN5 facilitates thyroid carcinoma cell proliferation and metastasis.
  • CSN5 positively correlates with ANGPTL2 levels in thyroid carcinoma.
  • CSN5 promotes thyroid carcinoma progression by upregulating ANGPTL2 via direct binding and reduced degradation.

Conclusions:

  • CSN5 plays a crucial role in promoting thyroid carcinoma development.
  • CSN5 enhances thyroid carcinoma cell proliferation and metastasis, partly through ANGPTL2.
  • CSN5 represents a potential therapeutic target for thyroid carcinoma treatment.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K